Immunological Abnormalities and Hepatotropic Viral Infections

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1992 Mar 1

PMID 1531946

Citations 4

Authors

I G McFarlane

Affiliations

Soon will be listed here.

Citing Articles

A case of autoimmune hepatitis following pegylated interferon treatment of chronic hepatitis delta.

Enc F, Ulasoglu C North Clin Istanb. 2020; 7(4):407-410.

PMID: 33043269 PMC: 7521096. DOI: 10.14744/nci.2019.47701.

A Case of Acute Autoimmune Hepatitis Superimposed on Chronic Hepatitis B Infection.

Sostre V, Patel H, Mohamed A, Volfson A Case Rep Gastrointest Med. 2018; 2018:2139607.

PMID: 29805819 PMC: 5899862. DOI: 10.1155/2018/2139607.

Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia.

Russi S, Sansonno D, Mariggio M, Vinella A, Pavone F, Lauletta G Arthritis Res Ther. 2014; 16(2):R73.

PMID: 24636026 PMC: 4060364. DOI: 10.1186/ar4513.

Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Sansonno D, Lauletta G, Montrone M, Tucci F, Nisi L, Dammacco F Clin Exp Immunol. 2006; 143(2):288-96.

PMID: 16412053 PMC: 1809584. DOI: 10.1111/j.1365-2249.2005.02987.x.

References

Konikoff F, Isenberg D, Barrison I, Theodor E, Shoenfeld Y . Antinuclear autoantibodies in chronic liver diseases. Hepatogastroenterology. 1989; 36(5):341-5. View

Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T . Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet. 1989; 2(8668):926. DOI: 10.1016/s0140-6736(89)91595-x. View

Wood J, Czaja A, Beaver S, Hall S, Ginsburg W, Kaufman D . Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatology. 1986; 6(5):976-80. DOI: 10.1002/hep.1840060528. View

McFarlane I . Autoreactivity against biliary tract antigens in primary biliary cirrhosis. Mol Aspects Med. 1985; 8(3):249-67. DOI: 10.1016/0098-2997(85)90009-3. View

Lawley T, James S, Jones E . Circulating immune complexes: their detection and potential significance in some hepatobiliary and intestinal diseases. Gastroenterology. 1980; 78(3):626-41. View

Laskus T, Slusarczyk J . Autoimmune chronic active hepatitis developing after acute type B hepatitis. Dig Dis Sci. 1989; 34(8):1294-7. DOI: 10.1007/BF01537282. View

OBrien C, Vento S, Donaldson P, McSorley C, McFarlane I, Williams R . Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet. 1986; 1(8477):350-3. DOI: 10.1016/s0140-6736(86)92318-4. View

HOMBERG J, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil S . Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 1987; 7(6):1333-9. DOI: 10.1002/hep.1840070626. View

McFarlane I, Williams R . Liver membrane antibodies. J Hepatol. 1985; 1(3):313-9. DOI: 10.1016/s0168-8278(85)80058-1. View

10.

Epstein O . The pathogenesis of primary biliary cirrhosis. Mol Aspects Med. 1985; 8(3):293-305. DOI: 10.1016/0098-2997(85)90011-1. View

11.

Minuk G, Angus M, Brickman C, Lawley T, Frank M, Hoofnagle J . Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology. 1985; 88(1 Pt 1):166-70. DOI: 10.1016/s0016-5085(85)80149-9. View

12.

Hopf U, Moller B . [Development of chronic active hepatitis of the autoimmune type following hepatitis B virus infection with HBSAg-persistence. 4 case reports]. Z Gastroenterol. 1984; 22(3):121-8. View

13.

Amoroso P, Vergani D, Wojcicka B, McFarlane I, Eddleston A, TEE D . Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis. Clin Exp Immunol. 1980; 42(1):95-8. PMC: 1537061. View

14.

Dammacco F, Sansonno D . Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol. 1992; 87(3):352-6. PMC: 1554325. DOI: 10.1111/j.1365-2249.1992.tb03001.x. View

15.

Garson J, Lenzi M, Ring C, Cassani F, Ballardini G, Briggs M . Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol. 1991; 34(4):223-6. DOI: 10.1002/jmv.1890340405. View

16.

Lenzi M, Johnson P, McFarlane I, Ballardini G, Smith H, McFarlane B . Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet. 1991; 338(8762):277-80. DOI: 10.1016/0140-6736(91)90418-o. View

17.

Disdier P, Harle J, Weiller P . Cryoglobulinaemia and hepatitis C infection. Lancet. 1991; 338(8775):1151-2. DOI: 10.1016/0140-6736(91)92014-s. View

18.

Poralla T, Treichel U, Lohr H, Fleischer B . The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis. 1991; 11(3):215-22. DOI: 10.1055/s-2008-1040439. View

19.

Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U . Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet. 1990; 335(8684):258-9. DOI: 10.1016/0140-6736(90)90070-l. View

20.

McFarlane I, Smith H, Johnson P, Bray G, Vergani D, Williams R . Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?. Lancet. 1990; 335(8692):754-7. DOI: 10.1016/0140-6736(90)90870-b. View